Infosys Ltd Share Value Analysis 2026
Founded in 1981 by Narayana Murthy and six engineers with $250 in capital, Infosys has grown into India’s second-largest IT services firm, providing consulting, technology, outsourcing, and digital transformation services across North America, Europe, and Asia. It is listed on the NSE, BSE, and NYSE, and is a constituent of the Nifty 50 and BSE Sensex.
The company’s service portfolio spans Digital Services (AI/analytics, cloud, cybersecurity, engineering), Core Services (application development, ERP via SAP/Oracle/Salesforce, BPM), and Platforms (Finacle for banking, Equinox for commerce, Topaz for enterprise AI, Cobalt for cloud). Geographically, North America contributes approximately 59% of revenues, Europe around 26%, and the rest of world the balance.
Infosys’s key verticals include Financial Services & Insurance (~29%), Manufacturing (~15%), Energy/Utilities/Telecom/Hi-Tech (~26%), Retail, Consumer & Logistics (~15%), and Life Sciences/Healthcare (~15%). The company has strategic collaborations with Intel, Microsoft, and Anthropic for AI-led enterprise transformation.
| Metric | FY22 | FY23 | FY24 | FY25 | FY26E* |
|---|---|---|---|---|---|
| Revenue (₹ Cr) | 1,21,641 | 1,46,767 | 1,53,670 | 1,65,590 | ~1,73,000 |
| Rev Growth YoY | 21% | 21% | 5% | 7.5% | ~4.5% |
| EBIT Margin | 23% | 21% | 20.7% | 21.0% | 20.5–21% |
| Net Profit (₹ Cr) | 22,110 | 24,095 | 26,248 | 26,248 | ~27,500 |
| EPS (₹) | 52.5 | 57.6 | 62.4 | 63.4 | ~66 |
| Dividend (₹/share) | 31 | 34 | 37 | 42 | ~44 |
| FCF ($ Mn) | 2,660 | 2,540 | 2,970 | 3,100 | ~3,400 |
* FY26E based on Q3 FY26 actuals + guidance of 3.0–3.5% CC growth and 20–22% EBIT margin. FY26 = Apr 2025 – Mar 2026.
The FY22–FY23 surge was driven by a post-pandemic tech spending boom. FY24 saw a sharp deceleration as clients cut discretionary IT budgets amid rising interest rates globally. FY25 showed a recovery, and FY26 guidance was upgraded from 2–3% to 3–3.5% CC after a strong Q3, underpinned by $4.8 billion in large deal wins (57% net new), including a £1.6 billion, 15-year NHS contract in the UK.
Q3 FY26 revenue came in at ₹45,479 crore (8.9% YoY), with reported EBIT margin at 18.4% — impacted by a one-time ₹1,289 crore provision related to new Indian Labour Codes. Adjusted operating margin was 21.2%, up 0.2pp sequentially, reflecting solid cost control. Free cash flow conversion remained strong at 113% of adjusted net profit.
Infosys has negligible debt (D/E of 0.11) and consistently converts 90%+ of net profit into free cash flow, making a pure FCF-based DCF appropriate. The base DCF assumes revenue growth accelerating from ~4.5% in FY26 to 9–10% by FY28–29, driven by AI services (Topaz), large deal ramp-ups (NHS, BFSI wins), and discretionary recovery in North America. A weaker rupee provides a natural earnings tailwind given ~85% USD/EUR revenue.
At CMP of ₹1,250, the stock trades at a ~20% discount to our base DCF value of ₹1,480–1,600. This discount reflects macro uncertainty — particularly US tariff impacts on client IT budgets, AI compression risks (productivity tools reducing billed hours), and a Nifty IT index that has corrected ~25% in 2026 so far.
At ₹1,250, Infosys is in the Accumulate zone — attractive for long-term investors but not a screaming buy, given macro headwinds and AI-led revenue compression risks. Q4 FY26 results on April 16, 2026 are a near-term catalyst. A strong Q4 beat with positive FY27 guidance could re-rate the stock toward ₹1,400–1,500 quickly. Any dip toward ₹1,150–1,180 (near 52W lows) would represent a high-conviction accumulation opportunity.
| Metric | FY26E | FY27E | FY28E |
|---|---|---|---|
| Revenue (₹ Cr) | ~1,73,000 | ~1,82,000 | ~1,98,000 |
| Revenue Growth (CC) | 3.0–3.5% | 4–6% | 7–9% |
| EBIT Margin | 20.5–21% | 20–21.5% | 21–22.5% |
| EPS (₹) | ~66 | ~72–76 | ~84–90 |
| Implied P/E @ ₹1,250 | 18.9× | 16.4–17.4× | 13.9–14.9× |
Infosys’s growth narrative is shifting from pure outsourcing to AI-led transformation. Nearly 90% of its top 200 clients are now actively using AI services. The Infosys Topaz platform (generative AI + agentic AI) is becoming a key differentiator in large deal pursuits. Q3 FY26 large deal TCV was $4.8 billion — the strongest in recent quarters — with the NHS mega-deal likely to contribute meaningfully to FY27 revenues.
Revenue acceleration from FY27 onwards is predicated on: (1) discretionary IT spending recovery in North America, (2) ramp-up of large deals signed in FY26, (3) increasing AI monetisation through Topaz, and (4) acquisitions — Optimum Healthcare IT ($465M) and Stratus (insurance consulting), both announced in March 2026, adding high-margin SaaS revenue. Margin stability is supported by automation, offshore leverage, and pyramid rationalisation.
The dividend payout ratio has averaged ~66% over 3 years, with a current yield of 3.54% — providing a meaningful floor return while investors wait for growth acceleration. Additionally, Infosys completed its largest-ever share buyback of ₹18,000 crore in FY26, demonstrating capital return discipline.
| Company | Mkt Cap (₹ Cr) | P/E (TTM) | Rev Growth (FY26E CC) | EBIT Margin | ROE (3yr) | Div Yield |
|---|---|---|---|---|---|---|
| Infosys (INFY) | 5,10,000 | 18.5× | 3.0–3.5% | 21.0% | 30.7% | 3.54% |
| TCS | 13,50,000 | 24× | ~4% | 24.5% | 52% | 1.8% |
| HCL Technologies | 4,80,000 | 21× | 5–6% | 18–19% | 26% | 3.2% |
| Wipro | 2,40,000 | 18× | ~2% | 17–18% | 17% | 2.5% |
| Sector Median | — | ~21× | 3–4% | 20–22% | ~27% | ~2.5% |
Infosys screens attractively against peers at 18.5× P/E — a meaningful discount to TCS (24×) and the sector median (~21×). This gap is explained partly by TCS’s superior margins and scale advantages, and partly by Infosys’s slower FY26 growth relative to HCL Tech. However, Infosys trades at comparable multiples to Wipro despite substantially higher ROE, margins, and growth trajectory, suggesting Infosys is the better value in the mid-to-large IT space.
HCL Tech is the peer growing fastest (~5–6% CC), but its product and platforms segment introduces lumpiness, and near-term margin guidance has been revised down. Infosys’s Topaz AI platform is increasingly competitive with HCL’s software business. Among large-cap IT, Infosys currently offers the best combination of dividend yield (3.54%), valuation discount, and growth optionality — making it the preferred long-term accumulation name in the sector.
DISCLAIMER: This report is prepared for informational and educational purposes only. It does not constitute investment advice, a solicitation, or an offer to buy or sell any security. The author is not a SEBI-registered research analyst. All data sourced from public filings, company disclosures, and third-party financial databases as of March 31, 2026. Past performance is not indicative of future results. Equity investments are subject to market risk. Readers should consult a qualified financial advisor before making investment decisions. DCF valuations and price targets are estimates based on assumptions that may not materialise. This report contains no conflicts of interest disclosure as it is independently produced.
